Physician profile
Jarad Fingerman
NPI 1376529966
$3,966.79
in general payments reported to CMS, 2019-2025
42 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,195 · 2020: $708 · 2021: $1,452 · 2022: $224 · 2023: $120 · 2024: $102 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $612.48 | 2019-2022 | |
| Janssen Biotech, INC. | $426.81 | 2019-2025 | Erleada |
| Procept Biorobotics Corporation | $399.45 | 2019-2023 | Aquabeam Robotic System |
| Boston Scientific Corporation | $241.01 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $187.28 | 2019-2022 | |
| Axonics, INC. | $177.08 | 2020-2021 | |
| Pfizer INC. | $164.26 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $163.73 | 2019-2021 | |
| Allergan, INC. | $159.33 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $153.42 | 2020-2022 | |
| Dendreon Pharmaceuticals LLC | $121.48 | 2019-2025 | Provenge |
| Amgen INC. | $118.59 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $102.16 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Abbvie INC. | $80.53 | 2019-2022 | |
| Teleflex LLC | $79.43 | 2021-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarad Fingerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.